Hospital News and Research

RSS

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

A pioneering surgical technique has restored some hand and arm movement to patients immobilized by spinal cord injuries in the neck, reports a new study at Washington University School of Medicine in St. Louis.

12 Oct 2015

York scientists target specific sodium channel to prevent breast cancer

Scientists at the University of York, using clinical specimens from charity Breast Cancer Now's Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.

12 Oct 2015

People often end up in emergency room because of infection-related falls

People who end up in the emergency room because of a fall often are tripped up by an infection, rather than a loose throw rug or poor eyesight, suggests a study being presented at IDWeek 2015.

12 Oct 2015

Study opens new doors to research possible treatment for patients suffering from neuropathic pain

Chronic pain results from disease or trauma to the nervous system. Damaged nerve fibres with heightened responses to normal stimuli send incorrect messages to pain centres in the brain. This phenomenon, called "peripheral and central sensitization" is one of the key mechanisms involved in the condition which touches people with diabetes, cancer, and those suffering from multiple sclerosis, among others.

12 Oct 2015

UV robots help reduce rates of C. diff transmission among cancer inpatients

Robots are capable of all sorts of tasks to help better treat cancer: They connect oncologists to patients remotely, make incisions, staple them shut, deliver "nano" therapies--and they clean rooms. New research from Penn Medicine infection control specialists found that ultraviolet (UV) robots helped reduce the rates transmission of the common bacterial infection known as Clostridium difficile among cancer inpatients - mostly blood cancer patients, a group more vulnerable to hospital-acquired infections - by 25 percent. The interventions also saved about $150,000 in annual direct medical costs.

12 Oct 2015

Novel mathematical method may help reduce development of antibiotic-resistant bacteria

It is estimated that each year in the United States 2 million people become infected with bacteria that are resistant to one or more types of antibiotics, and at least 23,000 people will die because of these infections. This problem is being exacerbated by overuse of antibiotics for livestock and also in community clinical practice. This overuse, combined with the slow pace of novel drug discovery is a growing threat to public health.

12 Oct 2015

YK-4-279 compound works against some forms of leukemia: Study

A compound discovered and developed by a team of Georgetown Lombardi Comprehensive Cancer Center researchers that halts cancer in animals with Ewing sarcoma and prostate cancer appears to work against some forms of leukemia, too.

12 Oct 2015

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

The U.S. Food and Drug Administration today allowed marketing of the first cerebrospinal fluid (CSF) nucleic acid-based test for simultaneous detection of multiple pathogens that can cause central nervous system infections.

12 Oct 2015

Magnet hospitals have higher patient ratings of care than other hospitals

Patients' experience with healthcare has become the focal point for quality improvement among hospitals and care providers. The Affordable Care Act incentivizes hospitals to improve patient satisfaction by paying a financial incentive to hospitals that achieve high ratings from patients.

12 Oct 2015

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

12 Oct 2015

Cancer survival outcomes can vary widely among U.S. hospitals

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available administrative data derived from Medicare claims, which lacks information about cancer stage. Two hospitals providing equally good care may have different survival rates if one hospital treats sicker patients, for example.

12 Oct 2015

Siloam Hospitals recognized with 2015 Frost & Sullivan Indonesia Hospital of the Year award

Siloam Hospitals has been honored with the 2015 Frost & Sullivan Indonesia Hospital of the Year award for the fourth time at the Indonesia Excellence Awards banquet.

11 Oct 2015

New test for heart attack may save NHS millions

A simple blood test could be used to rule out the possibility of heart attack in two-thirds of people who attend A&E with chest pains, report UK researchers.

9 Oct 2015

Scientists calculate precise measurements of heritability in nine pediatric-onset autoimmune diseases

Scientists have calculated more precise measurements of heritability--the influence of underlying genes--in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.

9 Oct 2015

Scientists engineer stem cells to better understand mechanisms behind leukemia

Scientists engineered stem cells to better understand the mechanisms behind a form of leukemia caused by changes in a key gene, according to a study led by Mount Sinai researchers and published online today in the journal Cell Reports.

9 Oct 2015

Roche to acquire biotechnology company, Adheron Therapeutics

Adheron Therapeutics, a privately held biotechnology company based in Berkeley, California, United States, announced today that it has agreed to be acquired by Roche.

9 Oct 2015

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Despite decades of study, schizophrenia has remained stubbornly difficult to diagnose in its earliest stage - between the appearance of symptoms and the development of the disorder. Now, a new analysis led by researchers at the UNC School of Medicine and the Renaissance Computing Institute identified illogical thoughts as most predictive of schizophrenia risk.

9 Oct 2015

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

Johnson & Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.

9 Oct 2015

Scientists map EGFRvIII mutant that causes brain cancer

A team of Ludwig Cancer Research scientists has mapped out how a mutant version of the epidermal growth factor receptor (EGFR) known as EGFRvIII specifically drives critical processes that alter the reading of the genome to fuel the growth of the brain cancer glioblastoma multiforme (GBM) and--most important--how each process is linked to the other.

9 Oct 2015

ASA member to teach perioperative anesthesia care to Rwandan physician anesthesiologists

American Society of Anesthesiologists (ASA) Global Humanitarian Outreach (GHO) volunteer Megan Olejniczak, M.D., will travel to Rwanda on Monday, October 19, to participate in a teaching program at the two teaching hospitals of the National University of Rwanda in the cities of Kigali and Butare.

9 Oct 2015

Hospital News and Research

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

York scientists target specific sodium channel to prevent breast cancer

People often end up in emergency room because of infection-related falls

Study opens new doors to research possible treatment for patients suffering from neuropathic pain

UV robots help reduce rates of C. diff transmission among cancer inpatients

Novel mathematical method may help reduce development of antibiotic-resistant bacteria

YK-4-279 compound works against some forms of leukemia: Study

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Magnet hospitals have higher patient ratings of care than other hospitals

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Cancer survival outcomes can vary widely among U.S. hospitals

Siloam Hospitals recognized with 2015 Frost & Sullivan Indonesia Hospital of the Year award

New test for heart attack may save NHS millions

Scientists calculate precise measurements of heritability in nine pediatric-onset autoimmune diseases

Scientists engineer stem cells to better understand mechanisms behind leukemia

Roche to acquire biotechnology company, Adheron Therapeutics

New analysis finds illogical thoughts as most predictive of schizophrenia risk

Safety and immunogenicity clinical trial of Ebola vaccine regimen starts in Sierra Leone

Scientists map EGFRvIII mutant that causes brain cancer

ASA member to teach perioperative anesthesia care to Rwandan physician anesthesiologists

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News